论文部分内容阅读
目的:本文旨在评估舒克菲治疗反流性咽喉炎的临床疗效。方法:门诊病人84例,分为3组,每组28例。A组服用舒克菲;B组服用西米替丁;C组是联合用药组,服用舒克菲和西米替丁。结果:A组显效18例,有效6例,总有效率为85.71％;B组显效15例,有效7例,总有效率为78.57％;C组显效22例,有效4例,总有效率为92.86％。舒克菲加用西米替丁与舒克菲单独用药差异无显著性(P>0.05)。结论:舒克菲作为粘膜保护剂治疗反流性咽喉炎,有其独特的药理作用,疗效肯定,未见明显副反应。
Purpose: This article aims to evaluate the clinical efficacy of Shu Kefei treatment of reflux pharyngitis. Methods: Outpatients 84 cases were divided into 3 groups, 28 cases in each group. Group A took Schofifei; Group B took cimetidine; Group C was a combination group, taking Shu Kefei and cimetidine. Results: A group of 18 cases markedly effective in 6 cases, the total effective rate was 85.71%; B group markedly effective in 15 cases, effective in 7 cases, the total effective rate was 78.57%; C group markedly effective in 22 cases, effective in 4 cases, the total effective rate was 92.86%. Shukifeijia with cimetidine and Shuke Fei alone was no significant difference (P> 0.05). Conclusion: Shu Kefei as a mucosal protective agent for the treatment of reflux pharyngitis, has its unique pharmacological effects, efficacy is affirmative, no obvious side effects.